Overview - Euro CTO · The CTO 2018 interactive program will enrich your educational experience at...

1
FEBRUARY 15-16, 2018 NEW YORK MARRIOTT MARQUIS I 1535 BROADWAY I NEW YORK, NY For more information, please visit crf.org/cto Overview Leading practitioners of percutaneous coronary intervention must become experts at recanalizing chronic total occlusions (CTO). With advanced techniques, success rates greater than 90% may be obtained. Achieving high success rates with minimal complications is dependent upon physicians being up-to-date on the most recent advances in operator technique, guidewire technology, and other adjunctive devices. Held in the heart of New York City, the Chronic Total Occlusion Summit 2018: A Live Case Demonstration Course brings together leaders in the field of CTO. Sessions will emphasize both advanced techniques and evidence-based medicine, with a heavy reliance on live case transmissions featuring the world’s leading experts in CTO PCI. Topics to be covered include: Fundamentals of CTO PCI Complex Retrograde and Antegrade CTO PCI Complication Prevention and Management How to Improve Outcomes Today Newest CTO and Complex PCI Techniques and Technologies Application of CTO PCI Techniques and Technologies in Non-CTO PCI Cases 2017 Essential CTO Updates Live Case Transmissions Edited Taped Case Presentations CTO Interactive Program The CTO 2018 interactive program will enrich your educational experience at the course. Part of the CRF Events App for your mobile device, the CTO 2018 interactive program gives you fingertip access to the agenda, presentation slides, and live streaming video, as well as the ability to rate sessions and other great features. CTO360 CTO360 delivers live and on-demand viewing of the Chronic Total Occlusion Summit 2018 during and for 30 days after the course.* Access to CTO360 is provided at no additional cost to all registered attendees. It is also available for a fee to those unable to attend. Satellite Programs Satellite programs at CTO 2018 provide meeting attendees with comprehensive insight into important topics and issues facing today’s interventional specialists. * Please note that CTO 2018 (including CTO360) is not CME-accredited. #CTO2018 crf.org/cto Live Case Site NewYork-Presbyterian/ Columbia University Medical Center New York, NY Course Directors Emmanouil S. Brilakis, MD, PhD Minneapolis Heart Institute Minneapolis, MN J. Aaron Grantham, MD University of Missouri Kansas City and Saint Luke’s Mid America Heart Institute Kansas City, MO Dimitri Karmpaliotis, MD, PhD NewYork-Presbyterian/ Columbia University Medical Center New York, NY Martin B. Leon, MD NewYork-Presbyterian/ Columbia University Medical Center New York, NY Jeffrey W. Moses, MD NewYork-Presbyterian/ Columbia University Medical Center New York, NY Masahiko Ochiai, MD Showa University Northern Yokohama Hospital Kanagawa, Japan Gregg W. Stone, MD NewYork-Presbyterian/ Columbia University Medical Center New York, NY Gerald S. Werner, MD Klinikum Darmstadt Darmstadt, Germany Learning Objectives By the end of this course, participants should be able to: • Identify the pathobiologic and clinical considerations associated with successful recanalization of chronic total occlusions • Explain how advances in operator technique, guidewire technology, and new devices have improved success rates for chronic total occlusions • Describe advanced guidewire techniques and other adjunctive devices, including the retrograde technique • Integrate the latest recommendations on how to use new guidewires and devices to optimize procedural success, while minimizing complications Target Audience This program is designed for interventional cardiologists, endovascular specialists, clinical cardiologists, catheterization laboratory nurses, cardiovascular technologists, and other healthcare professionals with a special interest in the field of chronic total occlusions. Activity Evaluation Online evaluation will address content, presentation, possible bias, and future educational needs. Disclosure Statement It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/ or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity. Discussion of off-label product usage and/or off-label product use during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity. Sunshine Act Compliance This activity is not CME-accredited, and therefore, the supporters are required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfers of value to US licensed physicians, including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the supporters of this program. The information provided will be used for reporting purposes only. Should you partake in this program, you will be reported as part of the Sunshine Act submission and will appear on the CMS Open Payments website on the next reporting cycle. REGISTER TODAY! #CTO2018 crf.org/cto

Transcript of Overview - Euro CTO · The CTO 2018 interactive program will enrich your educational experience at...

Page 1: Overview - Euro CTO · The CTO 2018 interactive program will enrich your educational experience at the course. Part of the CRF Events App for your mobile device, the CTO 2018 interactive

FEBRUARY 15-16, 2018NEW YORK MARRIOTT MARQUIS I 1535 BROADWAY I NEW YORK, NY

For more information, please visit crf.org/cto

OverviewLeading practitioners of percutaneous coronary intervention must become experts at recanalizing chronic total occlusions (CTO). With advanced techniques, success rates greater than 90% may be obtained. Achieving high success rates with minimal complications is dependent upon physicians being up-to-date on the most recent advances in operator technique, guidewire technology, and other adjunctive devices.

Held in the heart of New York City, the Chronic Total Occlusion Summit 2018: A Live Case Demonstration Course brings together leaders in the field of CTO.

Sessions will emphasize both advanced techniques and evidence-based medicine, with a heavy reliance on live case transmissions featuring the world’s leading experts in CTO PCI.

Topics to be covered include:Fundamentals of CTO PCI

Complex Retrograde and Antegrade CTO PCI

Complication Prevention and Management

How to Improve Outcomes Today

Newest CTO and Complex PCI Techniques and Technologies

Application of CTO PCI Techniques and Technologies in Non-CTO PCI Cases

2017 Essential CTO Updates

Live Case Transmissions

Edited Taped Case Presentations

CTO Interactive ProgramThe CTO 2018 interactive program will enrich your educational experience at the course. Part of the CRF Events App for your mobile device, the CTO 2018 interactive program gives you fingertip access to the agenda, presentation slides, and live streaming video, as well as the ability to rate sessions and other great features.

CTO360CTO360 delivers live and on-demand viewing of the Chronic Total Occlusion Summit 2018 during and for 30 days after the course.* Access to CTO360 is provided at no additional cost to all registered attendees. It is also available for a fee to those unable to attend.

Satellite ProgramsSatellite programs at CTO 2018 provide meeting attendees with comprehensive insight into important topics and issues facing today’s interventional specialists.

* Please note that CTO 2018 (including CTO360) is not CME-accredited.

#CTO2018crf.org/cto

Live Case SiteNewYork-Presbyterian/ Columbia University Medical Center New York, NY

Course DirectorsEmmanouil S. Brilakis, MD, PhD Minneapolis Heart Institute Minneapolis, MN

J. Aaron Grantham, MD University of Missouri Kansas City and Saint Luke’s Mid America Heart Institute Kansas City, MO

Dimitri Karmpaliotis, MD, PhD NewYork-Presbyterian/ Columbia University Medical Center New York, NY

Martin B. Leon, MD NewYork-Presbyterian/ Columbia University Medical Center New York, NY

Jeffrey W. Moses, MD NewYork-Presbyterian/ Columbia University Medical Center New York, NY

Masahiko Ochiai, MD Showa University Northern Yokohama Hospital Kanagawa, Japan

Gregg W. Stone, MD NewYork-Presbyterian/ Columbia University Medical Center New York, NY

Gerald S. Werner, MD Klinikum Darmstadt Darmstadt, Germany

Learning ObjectivesBy the end of this course, participants should be able to:

• Identify the pathobiologic and clinical considerations associated with successful recanalization of chronic total occlusions

• Explain how advances in operator technique, guidewire technology, and new devices have improved success rates for chronic total occlusions

• Describe advanced guidewire techniques and other adjunctive devices, including the retrograde technique

• Integrate the latest recommendations on how to use new guidewires and devices to optimize procedural success, while minimizing complications

Target AudienceThis program is designed for interventional cardiologists, endovascular specialists, clinical cardiologists, catheterization laboratory nurses, cardiovascular technologists, and other healthcare professionals with a special interest in the field of chronic total occlusions.

Activity EvaluationOnline evaluation will address content, presentation, possible bias, and future educational needs.

Disclosure StatementIt is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage and/or off-label product use during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Sunshine Act ComplianceThis activity is not CME-accredited, and therefore, the supporters are required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfers of value to US licensed physicians, including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the supporters of this program. The information provided will be used for reporting purposes only.

Should you partake in this program, you will be reported as part of the Sunshine Act submission and will appear on the CMS Open Payments website on the next reporting cycle.

REGISTER TODAY!

#CTO2018

crf.org/cto